Showing results (51-60 of 80) with videos related to
Sort By:
Pageof 8
Journal of Clinical Microbiology|February 1, 1991
Rapid, on-site diagnosis of chlamydial urethritis in men by detection of antigens in urethral swabs and urineJ Sellors, J Mahony, D Jang, et al.Journal of Clinical Microbiology|September 1, 1989
Diagnosis of Chlamydia trachomatis genital infections by cell culture and two enzyme immunoassays detecting different chlamydial antigensJ Mahony, S Castriciano, J Sellors, et al.The Journal of Infectious Diseases|January 1, 1990
Detection of Chlamydia trachomatis antigens in urine as an alternative to swabs and culturesM Chernesky, S Castriciano, J Sellors, et al.Blood|March 1, 1979
Results of treatment of Ph'+ chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol)I Cunningham, T Gee, M Dowling, et al.Translational Vision Science & Technology|December 23, 2015
Feasibility of Structural and Functional MRI Acquisition with Unpowered Implants in Argus II Retinal Prosthesis Patients: A Case StudySamantha I Cunningham, Yonggang Shi, James D Weiland, et al.Blood|March 15, 1990
Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantationK Offit, J P Burns, I Cunningham, et al.Pharmacology, Biochemistry, and Behavior|March 1, 2021
Samidorphan, an opioid receptor antagonist, attenuates drug-induced increases in extracellular dopamine concentrations and drug self-administration in male Wistar ratsJacobi I Cunningham, Mark S Todtenkopf, Reginald L Dean, et al.Bone Marrow Transplantation|January 1, 1994
Biological characterization of stem cell present in mobilized peripheral blood of CML patientsA S Tsukamoto, C Reading, A Carella, et al.Blood|June 1, 1990
Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemiaM Hauch, M V Gazzola, T Small, et al.The American Journal of Medicine|June 1, 1986
Treatment of stages I and II Hodgkin's disease with three different therapeutic modalitiesB Koziner, J Myers, C Cirrincione, et al.Pageof 8